While the profibrotic phenotype of myeloid cells in SSc may be due to a combination of factors, our finding suggest that the increased CCL2 and CCL7 levels in SSc patients (31, 34–36) may be in part due to Fli1 downregulation in Mo and could contribute to fibrosis. This evidence concerns the gene CCL2 and systemic sclerosis.